MCCC1 rs12637471: Understanding Genetic Risk and Parkinson's

What each genotype means

What is rs12637471?

The rs12637471 variant is a single nucleotide polymorphism (SNP) located within the MCCC1 gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is categorized as a trait-associated marker, meaning that researchers have observed it more frequently in individuals with certain health conditions compared to those without. It sits within the genomic region responsible for the MCCC1 gene, which provides instructions for building a critical enzyme in the body. Because this variant is located in a non-coding or regulatory region, it does not necessarily change the structure of the protein itself, but it may influence how much of the protein is produced or when it is expressed in different tissues, such as those in the brain.

The Role of the MCCC1 Gene

The MCCC1 gene provides the instructions for creating the alpha subunit of an enzyme called 3-methylcrotonoyl-CoA carboxylase (MCC). This enzyme is essential for the body's ability to break down leucine, an amino acid found in many proteins. The alpha subunits produced by MCCC1 combine with beta subunits from the MCCC2 gene to form a functional enzyme complex that requires biotin to operate. While severe mutations in this gene can lead to a rare metabolic disorder known as MCC deficiency, the rs12637471 variant is a common variation rather than a rare, disease-causing mutation. Its presence is not expected to cause metabolic deficiency, but rather serves as a subtle genetic signal that researchers use to study complex neurological conditions where the underlying biological mechanisms are still being mapped.

Associations with Parkinson's and Sleep Disorders

Current scientific literature, including data from the GWAS Catalog, has identified rs12637471 as a variant of interest in the study of neurodegenerative conditions. Specifically, it has been implicated in both Parkinson's disease and idiopathic REM sleep behavior disorder (RBD). RBD is a condition where individuals physically act out their dreams due to a loss of muscle atonia during sleep, and it is frequently considered a prodromal, or early, sign of neurodegenerative processes like Parkinson's. The association between this variant and both conditions suggests a shared genetic architecture or biological pathway that may contribute to the development of these disorders. However, the evidence strength for this association is currently considered moderate, meaning that while the statistical link is notable, it is not a definitive predictor of disease development.

Interpreting Your Genetic Information

It is important to understand that having a specific genotype for rs12637471 does not mean an individual will develop Parkinson's disease or REM sleep behavior disorder. Genetic risk factors are only one piece of a much larger puzzle that includes environmental exposures, lifestyle factors, and other genetic variants. Because this variant is associated with complex, multifactorial conditions, it cannot be used as a diagnostic tool. If you are concerned about your neurological health or sleep patterns, the most appropriate step is to consult with a neurologist or a sleep specialist. They can evaluate your clinical symptoms and family history, which are far more predictive of health outcomes than any single genetic marker. Never use genetic data to make medical decisions or to self-diagnose.

Frequently asked questions

Sources & further reading